| Literature DB >> 25886493 |
Dan Ye1, Jinglan Shan2, Yongbo Huang3,4, Jianchun Li5,6, Changan Li7, Xiaoqing Liu8,9, Weiqun He10,11, Yimin Li12,13, Pu Mao14.
Abstract
BACKGROUND: Imipenem-resistant Acinetobacter baumannii (IRAB) is an important cause of hospital-acquired infection. We aimed to describe an outbreak of IRAB infection and to investigate its possible source in an intensive care unit.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25886493 PMCID: PMC4415246 DOI: 10.1186/s12879-015-0917-9
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Schematic map of ICU showing the locations of samples that were positive for IRAB. (●) Patients with isolates positive for IRAB during environmental surveys in August, November, and December, 2011. (▲) Environmental samples positive for IRAB during environmental surveys in August, November, and December, 2011.
Figure 2Progression of IRAB outbreak in the ICU. Line indicates the hospital stay periods in the ICU. The gray block indicates the period of IRAB nosocomail infection. The shaded block represents the patients who were infected with IRAB before ICU admission.
Figure 3Monthly report of new cases of IRAB infection.
Demographic and clinical characteristics of case patients infected with IRAB, compared with non-infected control patients
|
|
|
|
|
|---|---|---|---|
| Age (years) | 65.09 ± 12.65 | 63.86 ± 14.33 | 0.824 |
| Gender, male (%) | 5 (45.46) | 5 (35.71) | 0.622 |
| Prior hospital stay (<1 year) | 3 (27.27) | 2 (14.29) | 0.420 |
| Length of stay in ICU (days) | 6 (3–25) | 11 (2.75–25.75) | 0.784 |
| APACHE II score upon ICU admission | 21.82 ± 7.13 | 21.50 ± 8.04 | 0.919 |
| SOFA score upon ICU admission | 6.55 ± 3.14 | 7.00 ± 6.49 | 0.762 |
| Primary ICU admission diagnosis | |||
| Chronic pulmonary disease | 8 (72.72) | 4 (28.57) | 0.028 |
| Pneumonia | 8 (72.72) | 8 (57.14) | 0.42 |
| Diabetes mellitus | 1 (9.09) | 2 (14.28) | 0.692 |
| Hypertension | 2 (18.18) | 5 (35.71) | 0.332 |
| Malignancy | 2 (18.18) | 3 (21.42) | 0.84 |
| Surgery procedure (<30 days) | 1 (9.09) | 5 (35.71) | 0.122 |
| Antibiotic classesb | |||
| Carbapenem | 7 (63.63) | 6 (42.86) | 0.302 |
| Penicillins | 3 (27.27) | 6 (42.56) | 0.420 |
| Piperacillin/tazobactam | 5 (45.45) | 6 (42.86) | 0.897 |
| Cefepime | 7 (63.63) | 6 (42.86) | 0.302 |
| Fluoroquinolones | 3 (27.28) | 3 (21.42) | 0.734 |
| Glycopeptide | 6 (54.54) | 8 (57.14) | 0.716 |
| Antifungal | 4 (36.36) | 4 (28.57) | 0.678 |
| ICU procedures | |||
| Ventilator | 11 (100) | 14 (100) | -- |
| Blood transfusion | 5 (45.45) | 7 (50) | 0.821 |
| Hemodialysis | 0 (0) | 4 (28.57) | 0.053 |
| Nasogastric tube | 11 (100) | 12 (85.71) | 0.191 |
| Venous central catheter | 10 (81.82) | 13 (92.86) | 0.859 |
| Peripheral venous catheter | 11 (100) | 13 (92.86) | 0.366 |
| Arterial catheter | 4 (36.36) | 6 (42.86) | 0.742 |
| Urinary catheter | 11 (100) | 14 (100) | -- |
| Outcome | |||
| 28-day mortality | 3 (27.27) | 2 (14.29) | 0.420 |
| Hospital mortality | 6 (54.56) | 3 (21.42) | 0.032 |
aAll data are presented as the number, with the percentage in parenthesis, with the exception of age, APACHE II score, and SOFA score, which are presented as mean ± standard deviation. Length of ICU stay was presented as median (interquartile range).
bCase group: used within 30 days before the first IRAB isolate was discovered and the antibiotics had been used for at least 72 h. Control group: antibiotics had been used in the ICU for at least 72 h.
Figure 4Rep-PCR-based similarity analysis and gel images for 39 IRAB isolates from clinical and environmental samples. Number presents the nember of beds. BC: bedside cabinet; BR: bed rail; C: curtain; G: gloves; H: hand; KB: computer keyboard; KB ST: computer keyboard at nurses’ station; M: mattress; P: patient; SC: supply cart; VCP: ventilator control panel; VS: ventilator air flow sensor.